Published in Am J Med on November 01, 1984
Does tumor status influence cancer patients' satisfaction with the doctor-patient interaction? Support Care Cancer (2003) 0.89
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM (1998) 2.81
Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart (1997) 1.90
Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation (2001) 1.73
Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol (1987) 1.49
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood (1998) 1.48
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood (1996) 1.42
A piece of my mind. Cognocardiology. JAMA (1993) 1.39
Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart (2011) 1.28
External noninvasive temporary cardiac pacing: clinical trials. Circulation (1985) 1.26
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J (1995) 1.21
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant (2001) 1.20
Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med (1987) 1.18
Scanning electron microscopy of developing plant organs. Science (1970) 1.14
A coupling factor for photosynthetic phosphorylation from plastids of light- and dark-grown maize. Biochim Biophys Acta (1971) 1.12
Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation (1997) 1.10
Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol (1985) 1.09
Amyloidosis. Postgrad Med J (2001) 1.05
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med (2001) 1.04
Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials. Eur Heart J (1996) 1.02
Safety and efficacy of noninvasive cardiac pacing. A preliminary report. N Engl J Med (1983) 1.02
Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol (1996) 1.01
Streptococcus bovis endocarditis and colonic cancer. Lancet (1978) 1.00
Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol (1984) 0.98
Resolution of heart failure in patients with AL amyloidosis. Ann Intern Med (1996) 0.97
Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol (1983) 0.97
Paradoxical increase in heart rate before conversion to sinus rhythm in patients with recent-onset atrial fibrillation. Am J Cardiol (1990) 0.96
Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med (1998) 0.95
Optimal number of beats for the Doppler measurement of cardiac output in atrial fibrillation. J Am Soc Echocardiogr (1997) 0.93
Prosthetic valve endocarditis resulting from Nocardia asteroides. Br Heart J (1979) 0.93
Immunological distinction between fraction I protein and protochlorophyllide holochrome. Plant Physiol (1969) 0.92
A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid (1999) 0.92
Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol (1997) 0.91
Klippel-Feil syndrome associated with aortic coarctation. Br Heart J (1976) 0.90
Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation (1998) 0.90
Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol (1991) 0.90
The heart in sickle cell anemia. Arch Intern Med (1982) 0.90
Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest (1993) 0.88
Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol (1997) 0.88
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol (1997) 0.88
Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card? Chest (1998) 0.86
Mental distress in patient on disopyramide. Lancet (1977) 0.85
Selective binding of nifedipine to amyloid fibrils. Am J Cardiol (1985) 0.84
Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter. Chest (1987) 0.84
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant (2004) 0.84
PFO or UFO? The role of a patent foramen ovale in cryptogenic stroke. Am Heart J (1991) 0.83
Values of some biochemical constituents in the serum of clinically-normal sheep. Aust Vet J (1974) 0.81
Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Radiology (1983) 0.81
Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol (1995) 0.81
Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival. Am J Cardiol (1995) 0.80
Positional supraventricular tachycardia. N Engl J Med (1981) 0.80
Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction? Am J Cardiol (2000) 0.79
Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. Am Heart J (1997) 0.79
A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient. Amyloid (1999) 0.78
Medication in acute myocardial infarction -- does it do as much harm as good? Med Hypotheses (1979) 0.78
External noninvasive cardiac pacing in out-of-hospital cardiac arrest. Crit Care Med (1983) 0.78
External cardiac pacing during in-hospital cardiac arrest. Am J Cardiol (1986) 0.78
The effect of chemical fixation on the fretwork of chloroplasts. Trans Am Microsc Soc (1967) 0.78
Pacemaker therapy in patients with atrial fibrillation. Am Heart J (1993) 0.77
Clinical value of a new Doppler index in cardiac amyloidosis. J Am Coll Cardiol (1997) 0.77
New criteria for diagnosis of regular, wide-complex tachycardias. Circulation (1992) 0.76
S1 in Wolff-Parkinson-White syndrome. Am J Cardiol (2000) 0.75
Restrictive cardiomyopathy. N Engl J Med (1997) 0.75
Digoxin: mythology or evidence? Ann Intern Med (1991) 0.75
Ventricular fibrillation following high potency intravenous vitamin injection. Postgrad Med J (1979) 0.75
Predictive value of P wave-triggered signal averaging of the electrocardiogram. Circulation (1991) 0.75
QT interval in cardiac amyloidosis. Clin Cardiol (1996) 0.75
A response to the letter on electrical cardioversion resulting in death from synchronization failure. Am J Cardiol (1995) 0.75
Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J (1990) 0.75
Scanning electron microscope observations of herbicide dispersal using cathodoluminescence as the detection mode. Plant Physiol (1973) 0.75
Patent foramen ovale and paradoxical emboli as a possible mechanism of stroke in patients with low FEV1. Stroke (1996) 0.75
Is pharmacologic cardioversion of atrial fibrillation really preferable to electrical cardioversion? J Am Coll Cardiol (1998) 0.75
Intravascular haemolysis after valve replacement: comparative study between Starr-Edwards (ball valve) and Björk-Shiley (disc valve) prosthesis. Thorax (1979) 0.75
Adverse reactions to medication on a coronary care unit. Postgrad Med J (1979) 0.75
Palpitations in idiopathic dilated cardiomyopathy. Am J Cardiol (1995) 0.75
Diuretics and digoxin in myocardial infarction. Br Med J (1977) 0.75
Signal-averaged P wave duration and atrial fibrillation. J Am Coll Cardiol (1994) 0.75
Effects of drugs on myocardial necrosis after subarachnoid haemorrhage. Br Med J (1978) 0.75
External cardiac pacing: influence of electrode placement on pacing threshold. Crit Care Med (1986) 0.75
The separation and determination of alpha-tocopherol and carotenoids in serum or plasma by paper chromatography. J Chromatogr (1968) 0.75
A scanning electron microscope study of the surface features of HeLa S3 suspension-culture cells treated with methylmercury(II). J Ultrastruct Res (1979) 0.75
Cardiac activation during external cardiac pacing. Pacing Clin Electrophysiol (1987) 0.75
Tobramycin and clindamycin in the treatment of febrile leukaemic patients. J Antimicrob Chemother (1977) 0.75
Verapamil-induced atrial fibrillation. N Engl J Med (1988) 0.75
Reproducibility of the catecholamine response to serial exercise testing in normals. Am J Med Sci (1992) 0.75
Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. Am J Cardiol (2000) 0.75
Pseudoparadoxic effect of atropine and carotid sinus massage on atrioventricular conduction in acute myocardial infarction. Chest (1986) 0.75
The preliminary communication 'Transcutaneous temporary pacing in the operating room'. JAMA (1986) 0.75
Images in clinical medicine. Pulsus alternans. N Engl J Med (1996) 0.75
Clinical application of external pacing. Am J Emerg Med (1984) 0.75
Atypical ventricular tachycardia or motion artifact? Am J Cardiol (1987) 0.75
Cardiac tamponade with refeeding in malnutrition. Am Heart J (1983) 0.75
Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias. Chest (1984) 0.75
Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol (1984) 0.75
Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serum. J Infect Dis (1976) 0.75
Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist. Cardiovasc Res (1981) 0.75
Electrical-induced sustained myocardial depolarization as a possible cause for transient ST elevation post-DC elective cardioversion. Am Heart J (1982) 0.75
Determination of lipids in biological materials by paper chromatography. J Chromatogr (1967) 0.75